124 — Lexington, Kentucky

124 is a clinical research site located in Lexington, Kentucky, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

124 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 124?

124 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 124 conducted?

124 has 1 clinical trials on record. Their work covers Epilepsy.

Is 124 accredited by Crixeo Health?

124 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 124?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.